Melanotan II (10 mg Vial) Dosage Protocol
Contents
- Quickstart Highlights
- Dosing & Reconstitution Guide
- Standard / Gradual Approach 2.0 mL = 5 mg/mL)
- Reconstitution Steps
- Supplies Needed
- Protocol Overview
- Dosing Protocol
- Storage Instructions
- Important Notes
- How This Works
- Potential Benefits & Side Effects
- Lifestyle Factors
- Injection Technique
- Recommended Source
- Important Note
- References
Quickstart Highlights
Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH), primarily studied for its role in increasing skin pigmentation. It has also been observed to influence libido and erectile response due to melanocortin receptor activity.
This protocol outlines a gradual subcutaneous dosing approach designed to minimize common side effects such as nausea and flushing while achieving consistent pigmentation results.
- Reconstitution: Add 2.0 mL bacteriostatic water → 5 mg/mL
- Typical Dose Range: 250–500 mcg daily
- Measurement: 1 unit (U-100 syringe) = ~50 mcg
- Storage:
- Lyophilized: −20°C
- Reconstituted: 2–8°C (use within 1–2 weeks)
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Titration (2 mL = 5 mg/mL)
| Week / Phase | Daily Dose | Units (U-100) | Frequency |
|---|---|---|---|
| Loading (1-8 Weeks) | 250 mcg | 5 units | Daily |
| Maintenance | 250 mcg | 5 units | 2-3x per week |
| PreSun | 500 mcg | 10 units | 2-4 hours before sun |
Maintenance (After Week 8):
250 mcg 2-3× weekly (5 units)
Administer via subcutaneous injection once daily during the initial 8-week tanning phase, then transition to 2-3 injections per week for maintenance to help sustain pigmentation.
This protocol uses a standard 2.0 mL dilution to ensure consistent and accurate unit measurements. For smaller doses (≤10 units / ≤0.10 mL), using 30- or 50-unit insulin syringes is recommended for better precision and easier readability.
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water using a sterile syringe
- Inject slowly into the vial (avoid foam formation)
- Gently swirl—do not shake
- Store refrigerated and protected from light
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- Peptide Vials (Melanotan II, 10 mg each):
- 8 weeks ≈ 2 vials (~20 mg total)
- 12 weeks ≈ 3 vials (~30 mg total)
- 16 weeks ≈ 4 vials (~40 mg total)
- Insulin Syringes (U-100, 1 mL):
- Per week (daily dosing): 7 syringes
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
- 8 weeks (2 vials): 4 mL → 1× 10 mL bottles
- 12 weeks (3 vials): 6 mL → 1 × 10 mL bottles
- 16 weeks (4 vials): 8 mL → 1 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
- Goal: Enhance skin pigmentation via melanocortin receptor activation
- Schedule: Daily injections for 6–8 weeks (loading phase)
- Maintenance: 1–2 injections per week
- Dose Range: 250–500 mcg daily
- Cycle Length: 8–12 weeks typical
Dosing Protocol
- Start at250 mcg daily
- Increase gradually every 1–2 weeks
- Transition to maintenance dosing after initial phase
- Inject at a consistent time and rotate sites
Storage Instructions
- Lyophilized: Store at −20°C in a dry, dark environment
- Reconstituted: Refrigerate at 2–8°C
- Avoid repeated freeze–thaw cycles
- Use within 2–3 weeks for best stability
- Allow vial to reach room temperature before opening
Important Notes
Key considerations for consistency, handling, and research accuracy.
- Always use a new, sterile insulin syringe for each administration; do not reuse needles
- Follow proper aseptic technique: clean both the vial stopper and injection site with separate alcohol swabs and allow to dry fully
- Rotate injection sites (abdomen, thighs, upper arms) to reduce irritation and avoid tissue buildup
- Administer injections slowly and steadily, allowing a few seconds before withdrawing the needle
- Keep a record of dosing, timing, and injection sites to maintain consistency throughout the protocol
- Do not use the solution if it appears cloudy, discolored, or contains visible particles
- Store and handle peptides according to recommended conditions to preserve stability
How This Works
Melanotan II works by activating melanocortin receptors (MC1R and MC4R).
- MC1R activation: Stimulates melanin production → darker skin tone
- MC4R activation: Influences appetite and sexual function
Effects build gradually with consistent dosing during the loading phase.
Potential Benefits & Considerations
Potential Benefits of Melanotan II
- Supports a deeper, more even tan: Helps stimulate melanin production in the skin, allowing you to develop a darker, more consistent tan with less overall sun exposure compared to traditional tanning methods.
- Promotes longer-lasting color: By increasing natural pigmentation, the tan achieved is often more durable and fades more slowly, helping maintain results over time.
- May reduce sunburn risk: Increased melanin levels can provide a level of natural protection, which may help reduce the likelihood of burning when exposed to sunlight (still not a replacement for sunscreen).
- Creates a more natural-looking tan: Helps reduce patchiness and uneven tones, leading to smoother, more uniform skin coloration.
- Can enhance libido and arousal: Melanotan II is commonly associated with increased sexual desire and spontaneous arousal in both men and women due to its effects on melanocortin receptors.
- May improve skin appearance: Some users report a healthier-looking complexion, with improved overall tone and a more vibrant appearance.
- Supports tanning in hard-to-tan individuals: Particularly useful for those with fair skin or who struggle to develop a tan naturally.
- Potential appetite suppression effects: Some individuals report reduced appetite, which may support weight management efforts (effects can vary).
- Convenient alternative to excessive sun exposure: Allows users to achieve desired tanning results without prolonged UV exposure, which can help reduce long-term skin damage when used responsibly.
Common Side Effects
- Nausea (most common)
- Facial flushing
- Reduced appetite
- Fatigue
- Injection site irritation
Serious Risks & Warnings
- Not FDA-approved
- Possible changes in moles or pigmentation
- Cardiovascular stimulation at higher doses
- High-dose toxicity risks (avoid excessive dosing)
Lifestyle Factors
- Use sun protection even if tanning increases
- Stay well hydrated
- Monitor skin and moles regularly
- Maintain disciplined dosing (avoid overuse)
Injection Technique
General guidance for subcutaneous administration:
- Clean the vial stopper and injection area with alcohol and allow to dry
- Gently pinch the skin and insert the needle at a 45–90° angle
- Inject slowly and steadily without aspirating
- Hold the needle in place for a few seconds before removing
- Rotate injection sites (abdomen, thighs, upper arms) to reduce irritation
Recommended Source
We recommend Fit Aminos for high-purity Melanoton II – 10mg
Why Fit Aminos?
- High-purity, lab-tested peptide batches with quality verification.
- Consistent handling and preparation processes designed to support reliable research protocols.
- Transparent sourcing and dependable fulfillment for research-grade compounds.
Shop Melanoton II – 10mg at Fit Aminos
Important Note
This content is intended for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment. Melanoton II – 10mg remains an investigational peptide with limited human clinical data. For research use only. Not for human consumption.
References
PubMed — Dorr RT et al. (1996) — Phase I clinical study of melanotan-II, evaluation of dosing and safety in healthy volunteers
International Peptide Society — Melanotan II Monograph — Comprehensive peptide monograph covering dosing protocols and titration guidance
DermNet NZ — Melanotan II Information for Patients — Clinical dermatology guidance on melanotan use, side effects, and maintenance dosing
PubMed — Nelson ME et al. (2012)
— Case report: Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
RxList — Melanotan-II Uses, Side Effects and Dosing
— Medical database overview of melanotan-II pharmacology and clinical effects